MedPath

Patient preferences for treatment of Hidradenitis suppurativa

Conditions
L73.2
Hidradenitis suppurativa
Registration Number
DRKS00018787
Lead Sponsor
niversitätsmedizin Göttingen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
223
Inclusion Criteria

Dated and signed consent form
- Patients with physician-diagnosed Hidradenitis suppurativa, irrespective of disease severity or current or former therapy
- Age = 18 Jahre
- Ability to understand discrete choice experiments

Exclusion Criteria

Any member of the study team who is directly or indirectly involved in the study

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The objective of the study is the identification of patient preferences for outcome and process attributes in the treatment of Hidradenitis suppurativa with medical (antibiotics, adalimumab) and surgical therapies.
Secondary Outcome Measures
NameTimeMethod
Subgroup analysis of patient preferences with regard to patient and disease characteristics
© Copyright 2025. All Rights Reserved by MedPath